Why We Should Care About Ion Channels “… ion channels are the most important single class of proteins that exist in the human body or any body…” Clay Armstrong
. What Are Ion Channels We all think differently and use different words/associations to describe the same thing. See how different scientists define ion channels. Fundamentals Nobel Prizes for the discoveries concerning ion channels Fundamentals History Of Ion Channels Fundamentals Ion Channel News: 22/12/2020 FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations 22/12/2020 Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders 18/12/2020 Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19 17/12/2020 Cadent Therapeutics and its ion channel programs to be acquired by Novartis 16/12/2020 Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain 15/12/2020 TetraGenetics announces discovery of functional antibodies against Nav1.8 12/12/2020 QurAlis’ selective KCNQ2/3 opener, QRA-244, demonstrates up to 20-fold increase in potency and dramatic reduction in side effects compared to retigabine Read more news here Chief Scientific Officer at Nanion, Andrea Brüggemann, on automated patch clamp in academia, ion channel industry and fundraising INTERVIEWS Ion Channel DRUGS Resource Ion Channel COMPANIES Resource Ion Channel LABS Resource Membrane Transport Infographic Electrical Signals Infographic Permeability Of Lipid Bilayers Infographic
What Are Ion Channels We all think differently and use different words/associations to describe the same thing. See how different scientists define ion channels. Fundamentals
22/12/2020 FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations 22/12/2020 Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders 18/12/2020 Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19 17/12/2020 Cadent Therapeutics and its ion channel programs to be acquired by Novartis 16/12/2020 Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain 15/12/2020 TetraGenetics announces discovery of functional antibodies against Nav1.8 12/12/2020 QurAlis’ selective KCNQ2/3 opener, QRA-244, demonstrates up to 20-fold increase in potency and dramatic reduction in side effects compared to retigabine
Chief Scientific Officer at Nanion, Andrea Brüggemann, on automated patch clamp in academia, ion channel industry and fundraising INTERVIEWS